Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women
- 1 July 2021
- journal article
- research article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 225 (1), 85.e1-85.e11
- https://doi.org/10.1016/j.ajog.2020.11.035
Abstract
No abstract availableFunding Information
- National Institutes of Health
- National Center for Advancing Translational Sciences
- George Washington University
- University of Maryland
This publication has 44 references indexed in Scilit:
- Clarification on Precision Criteria to Derive Sample Size When Designing Pediatric Pharmacokinetic StudiesThe Journal of Clinical Pharmacology, 2012
- Principles and Practice of Thromboelastography in Clinical Coagulation Management and Transfusion PracticeTransfusion Medicine Reviews, 2012
- Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in miceBlood, 2011
- Reference values for rotation thromboelastometry (ROTEM®) parameters following non-haemorrhagic deliveries. Correlations with standard haemostasis parametersThrombosis and Haemostasis, 2011
- Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trialThe Lancet, 2010
- Pregnancy and Laboratory StudiesObstetrics & Gynecology, 2009
- Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stabilityBlood, 2009
- Perioperative use of modified thrombelastography in factor XI deficiency: a helpful method to assess drug effectsActa Anaesthesiologica Scandinavica, 2007
- Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applicationsThe AAPS Journal, 2005
- Tranexamic Acid Reduces Blood Loss, Transfusion Requirements, and Coagulation Factor Use in Primary Orthotopic Liver TransplantationAnesthesiology, 1996